Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15041054
Abstract: Alzheimer’s disease (AD) is the most prevalent form of dementia. It affects more than 30 million people worldwide and costs over US$ 1.3 trillion annually. AD is characterized by the brain accumulation of amyloid β… read more here.
Keywords: alzheimer disease; nanotherapeutics alzheimer; multifunctional nanotherapeutics; derivatives multifunctional ... See more keywords